KIRKLAND, Wash., April 20, 2012 /PRNewswire/ -- A recent clinical trial conducted at Evergreen Healthcare shows that a new form of a common drug used to treat Parkinson's Disease greatly improves

A levodopa-carbidopa intestinal gel (LCIG) works better than standard oral levodopa-carbidopa in reducing "off" time in patients with advanced Parkinson's disease.

NEW ORLEANS, April 17, 2012 /PRNewswire-USNewswire/ -- A levodopa-carbidopa intestinal gel (LCIG) works better than standard oral levodopa-carbidopa in reducing "off" time in patients

ABBOTT PARK, Ill., April 17, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) announced today the results from a Phase 3 trial evaluating the company's investigational compound for advanced Parkinson's

NESS ZIONA, Israel, November 9, 2011 /PRNewswire/ -- NeuroDerm [http://www.neuroderm.com ], Ltd.